{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T08:21:03Z","timestamp":1794990063019,"version":"4.9.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["BCRF 17-035"],"award-info":[{"award-number":["BCRF 17-035"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xcrm.2025.102357","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:26:06Z","timestamp":1758619566000},"page":"102357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Drug screening in 3D microtumors reveals DDR1\/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblasts"],"prefix":"10.1016","volume":"6","author":[{"given":"Nao","family":"Nishida-Aoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maihi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus M.","family":"Ghajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana L.","family":"Welm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venu G.","family":"Pillarisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taranjit S.","family":"Gujral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102357_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drup.2012.01.006","article-title":"The tumor microenvironment is a dominant force in multidrug resistance","volume":"15","author":"Correia","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.xcrm.2025.102357_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.trecan.2018.10.002","article-title":"The multiple layers of the tumor environment","volume":"4","author":"Laplane","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2025.102357_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13058-016-0740-2","article-title":"Tumor-associated stromal cells as key contributors to the tumor microenvironment","volume":"18","author":"Bussard","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102357_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216564","article-title":"Integrated cancer tissue engineering models for precision medicine","volume":"14","author":"Bregenzer","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102357_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1670019","article-title":"Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery","volume":"8","author":"Sivakumar","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2025.102357_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/gutjnl-2021-325808","article-title":"Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases","volume":"72","author":"Sullivan","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2025.102357_bib7","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1039\/C9LC00811J","article-title":"A microfluidic platform for functional testing of cancer drugs on intact tumor slices","volume":"20","author":"Rodriguez","year":"2020","journal-title":"Lab Chip"},{"key":"10.1016\/j.xcrm.2025.102357_bib8","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2019.12.88","article-title":"Tumor slice culture as a biologic surrogate of human cancer","volume":"8","author":"Kenerson","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102357_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103623118","article-title":"Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer","volume":"118","author":"Bello","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102357_bib10","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202110426","article-title":"Machine learning identifies molecular regulators and therapeutics for targeting SARS-CoV2-induced cytokine release","volume":"17","author":"Chan","year":"2021","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.xcrm.2025.102357_bib11","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1073\/pnas.1403080111","article-title":"Exploiting polypharmacology for drug target deconvolution","volume":"111","author":"Gujral","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102357_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2024-334274","article-title":"DNAJ-PKAc fusion heightens PLK1 inhibitor sensitivity in fibrolamellar carcinoma","author":"Chan","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2025.102357_bib13","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41467-017-01345-2","article-title":"Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profiles","volume":"8","author":"Arang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102357_bib14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2014.10.032","article-title":"A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis","volume":"159","author":"Gujral","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102357_bib15","article-title":"The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans","volume":"376","author":"Jones","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102357_bib16","doi-asserted-by":"crossref","first-page":"19472","DOI":"10.1074\/jbc.M414221200","article-title":"BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo","volume":"280","author":"Kuma","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102357_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/art.24266","article-title":"Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis","volume":"60","author":"Cohen","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.xcrm.2025.102357_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.trecan.2022.12.001","article-title":"Preclinical to clinical utility of ROCK inhibitors in cancer","volume":"9","author":"Barcelo","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2025.102357_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215800","article-title":"Early functional mismatch between breast cancer cells and their tumour microenvironment suppresses long term growth","volume":"544","author":"Perdrix Rosell","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2025.102357_bib20","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/s41418-019-0485-4","article-title":"Synergistic therapeutic effect of combined PDGFR and SGK1 inhibition in metastasis-initiating cells of breast cancer","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2025.102357_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102357_bib22","article-title":"Targeting the JAK\/STAT pathway in solid tumors","volume":"6","author":"Qureshy","year":"2020","journal-title":"J. Cancer Metastasis Treat."},{"key":"10.1016\/j.xcrm.2025.102357_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","article-title":"The present and future of the Cancer Dependency Map","volume":"25","author":"Arafeh","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102357_bib24","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/jvim.15847","article-title":"Effect of the p38 MAPK inhibitor doramapimod on the systemic inflammatory response to intravenous lipopolysaccharide in horses","volume":"34","author":"Bauquier","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.xcrm.2025.102357_bib25","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.4049\/jimmunol.168.8.4070","article-title":"Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia","volume":"168","author":"Branger","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102357_bib26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ajpath.2016.12.016","article-title":"Blockade of p38 mitogen-activated protein kinase inhibits murine sclerodermatous chronic graft-versus-host disease","volume":"187","author":"Matsushita","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2025.102357_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.addr.2015.12.017","article-title":"The extracellular matrix in breast cancer","volume":"97","author":"Insua-Rodriguez","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2025.102357_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102357_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102357_bib30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102357_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nsb770","article-title":"Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site","volume":"9","author":"Pargellis","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.xcrm.2025.102357_bib32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102357_bib33","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102357_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1097-2765(00)80003-9","article-title":"The discoidin domain receptor tyrosine kinases are activated by collagen","volume":"1","author":"Vogel","year":"1997","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2025.102357_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1053920","article-title":"Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer","volume":"14","author":"Strating","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102357_bib36","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.029447","article-title":"A peek into cancer-associated fibroblasts: origins, functions and translational impact","volume":"11","author":"LeBleu","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.xcrm.2025.102357_bib37","first-page":"324","article-title":"DDR1 and DDR2 physical interaction leads to signaling interconnection but with possible distinct functions","volume":"12","author":"Croissant","year":"2018","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.xcrm.2025.102357_bib38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00044-020-02694-2","article-title":"DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent","volume":"30","author":"Matada","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.xcrm.2025.102357_bib39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0168-9525(99)01840-5","article-title":"Gli proteins and Hedgehog signaling: development and cancer","volume":"15","author":"Ruiz i Altaba","year":"1999","journal-title":"Trends Genet."},{"key":"10.1016\/j.xcrm.2025.102357_bib40","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0609699104","article-title":"Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists","volume":"104","author":"Lauth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102357_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2025.102357_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188444","article-title":"Cancer-associated fibroblasts in therapeutic resistance of pancreatic cancer: Present situation, predicaments, and perspectives","volume":"1874","author":"Han","year":"2020","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102357_bib43","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102357_bib44","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102357_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","article-title":"Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion","volume":"599","author":"Sun","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102357_bib46","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1158\/1541-7786.MCR-17-0710","article-title":"Inhibition of discoidin domain receptor 1 prevents stroma-induced peritoneal metastasis in gastric carcinoma","volume":"16","author":"Jin","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102357_bib47","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.3390\/cancers14143482","article-title":"DDR2 expression in cancer-associated fibroblasts promotes ovarian cancer tumor invasion and metastasis through periostin-ITGB1","volume":"14","author":"Akinjiyan","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2025.102357_bib48","article-title":"DDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling","volume":"69","author":"Qing","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.xcrm.2025.102357_bib49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41416-019-0683-3","article-title":"Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma","volume":"122","author":"De Jesus-Acosta","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102357_bib50","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102357_bib51","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nature09627","article-title":"COT drives resistance to RAF inhibition through MAP kinase pathway reactivation","volume":"468","author":"Johannessen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102357_bib52","article-title":"KiRNet: Kinase-centered network propagation of pharmacological screen results","volume":"1","author":"Bello","year":"2021","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.xcrm.2025.102357_bib53","doi-asserted-by":"crossref","DOI":"10.3791\/61036","article-title":"Measuring real-time drug response in organotypic tumor tissue slices","author":"Nishida-Aoki","year":"2020","journal-title":"JoVE J."},{"key":"10.1016\/j.xcrm.2025.102357_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.biocel.2016.10.014","article-title":"Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments","volume":"81","author":"Goddard","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102357_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010024","article-title":"A system-wide investigation of the dynamics of Wnt signaling reveals novel phases of transcriptional regulation","volume":"5","author":"Gujral","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102357_bib56","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.celrep.2015.12.080","article-title":"Kinase inhibitor profiling reveals unexpected opportunities to inhibit disease-associated mutant kinases","volume":"14","author":"Duong-Ly","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.102357_bib57","article-title":"An optimal set of inhibitors for Reverse Engineering via Kinase Regularization","author":"Rata","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2025.102357_bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:13:51Z","timestamp":1788563631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666379125004306"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102357","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug screening in 3D microtumors reveals DDR1\/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102357"}}